Public Perception and Policy for SARS-CoV-2 Whole Genome Sequencing and Genomics for All

Launched by INDONESIA UNIVERSITY · May 31, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how people perceive and feel about a process called whole genome sequencing (WGS) for the SARS-CoV-2 virus, which causes COVID-19, and other types of genetic testing. Researchers believe that misunderstandings about these tests can make it hard for the government and the public to support their use, especially in countries with fewer resources. The goal of the study is to identify common beliefs and feelings about these tests, pinpoint any misconceptions, and then create targeted messages and materials to help educate the public and policymakers. This effort aims to boost support for using genetic sequencing as a valuable tool in managing the pandemic and other health issues.

To be eligible for this trial, participants must live or work in Jakarta and can include young adults, adults, the elderly, health workers, and those involved in public policy. If you decide to participate, you can expect to share your thoughts and feelings on these topics in a supportive environment. Your input will help shape better communication strategies to improve understanding and acceptance of genomic testing in the community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Living or working in Jakarta
• • Young adult
• • Adult
• • Elderly
• • Health workers
• • Public Policy
• Exclusion Criteria:
• • - Living or working outside Jakarta